Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 2 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Recs

0
Player Avatar emptygestures (< 20) Submitted: 12/14/2010 1:41:13 PM : Underperform Start Price: $1.53 ARNA Score: -286.59

No chance for approval

Featured Broker Partners


Advertisement